• 1
    Riggs BL, Wahner HW, Seeman E, Offord KP, Dunn WL 1982 Changes in bone mineral density of the proximal femur and spine with aging: Differences between the postmenopausal and senile osteoporosis syndrome J Clin Invest 70:716723.
  • 2
    Norimatsu H, Mori S, Uesaka T, Yoshikawa T, Katsuyama N 1989 Bone mineral density of the spine and proximal femur in normal and osteoporotic subjects in Japan Bone Miner 5:213222.
  • 3
    Kitazawa R, Fukase M, Imai Y, Sugimoto T, Kano J, Kaji H, Fujita T 1993 Assessment of lumbar bone mineral density in normal Japanese women Osteoporos Int 3:S245.
  • 4
    Sugimoto T, Kanbara Y, Shiraishi H, Kawakatsu M, Negishi H, Fukase M, Fujita T, Chihara K, Tsutsumi M 1994 Femoral and spinal bone mineral density in Japanese osteoporotics with hip fracture Osteoporos Int 4:144148.
  • 5
    Civitelli R, Gonneli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C 1988 Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment J Clin Invest 82:12681274.
  • 6
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links J Clin Endocrinol Metab 72:367373.
  • 7
    Rosen CJ, Donahue LR, Hunter SJ 1994 Insulin-like growth factors and bone: The osteoporosis connection Exp Biol Med 206:83102.
  • 8
    Feyen JHM, Evans DB, Binkert C, Heinrich GF, Geisse S, Kocher HP 1991 Recombinant human [Cys281] insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor-I–stimulated proliferation and collagen synthesis in fetal rat calvariae J Biol Chem 266:1946919474.
  • 9
    Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action J Biol Chem 267:2246722472.
  • 10
    Schiltz PM, Mohan S, Baylink DJ 1993 Insulin-like growth factor binding protein-4 inhibits both basal and IGF-mediated chick pelvic cartilage growth in vitro J Bone Miner Res 8:391396.
  • 11
    Schwander JC, Hauri C, Zapf J, Froesch ER 1983 Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: Dependence on growth hormone status Endocrinology 113:297305.
  • 12
    Spencer EM, Liu CC, Si ECC, Howard GA 1991 In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats Bone 12:2126.
  • 13
    Johansson AG, Lindh E, Ljunghall S 1992 Insulin-like growth factor I stimulates bone turnover in osteoporosis Lancet 339:1619.
  • 14
    Corpas E, Harman SM, Blackman MR 1993 Human growth hormone and human aging Endocr Rev 14:2039.
  • 15
    O'halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency J Clin Endocrinol Metab 76:13441348.
  • 16
    Bing-You RG, Denis M-C, Rosen CJ 1993 Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3 Calcif Tissue Int 52:183187.
  • 17
    Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S 1994 Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men J Bone Miner Res 9:915921.
  • 18
    Baxter RC 1993 Circulating binding proteins for the insulinlike growth factors Trends Endocrinol Metab 4:9196.
  • 19
    Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency J Clin Endocrinol Metab 70:12921298.
  • 20
    Laron Z, Klinger B, Blum WF, Silbergeld A, Ranke MB 1992 IGF binding protein 3 in patients with Laron type dwarfism: Effect of exogenous rIGF-I Clin Endocriol 36:301304.
  • 21
    Corpas E, Harman SM, Blackman MR 1992 Serum IGF-binding protein-3 is related to IGF-I, but not to spontaneous GH release in healthy old men Horm Metab Res 24:543545.
  • 22
    Bennett AE, Wahner HW, Riggs BL, Hintz RL 1984 Insulin-like growth factor I and II: Aging and bone density in women J Clin Endocrinol Metab 59:701704.
  • 23
    Kelly PJ, Eisman JA, Stuart MC, Pocock NA, Sambrook PN, Gwinn TH 1990 Somatomedin-C, physical fitness, and bone density J Clin Endocrinol Metab 70:718723.
  • 24
    Ljunghall S, Johansson AG, Burman P, Lindh KE, Karlsson FA 1992 Low plasma levels of insulin-like growth factor I (IGF-I) in male patients with idiopathic osteoporosis J Intern Med 232:5964.
  • 25
    Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R 1993 Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis J Intern Med 234:249255.
  • 26
    Daughaday WH, Mariz IK, Blethen SL 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum J Clin Endocrinol Metab 51:781788.
  • 27
    Albertsson K, Hall K 1987 Growth hormone treatment in short children: Relationship between growth and serum insulin-like growth factor I and II levels J Clin Endocrinol Metab 65:671678.
  • 28
    Reid IR, Plank LD, Evans MC 1992 Fat mass is an important determinant of whole body bone density in premenopausal women but not in men J Clin Endocrinol Metab 75:779782.
  • 29
    Melton LJ, Chao EYS, Lane J, 1988 Biomechanical aspects of fractures. In: RiggsBL, MeltonLJ, (eds.) Osteoporosis: Etiology, Diagnosis, and Management. Raven Press, New York, NY, U.S.A., pp. 111131.
  • 30
    Blum WF, Ranke MB 1990 Insulin-like growth factor binding proteins (IGFBPs) with special reference to IGFBP-3 Acta Paediatr Scand (Suppl) 367:5562.
  • 31
    Sklar C, Sarafoglou K, Whittam E 1993 Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation Acta Endocrinol 129:511515.
  • 32
    Zapf J, Schmid C, Guler HP, Wahdvogel M, Hauri CH, Futo E, Hossenlopp P, Binoux M, Froesch ER 1990 Regulation of binding proteins for insulin-like growth factors (IGFs) in humans: Increased expression of IGF binding protein 2 during IGF-I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia J Clin Invest 86:952961.
  • 33
    Young SCJ, Underwood LE, Celniker A, Clemmons DR 1992 Effect of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults J Clin Endocrinol Metab 75:603608.
  • 34
    Amarnani S, Merriman HL, Linkhart TA, Baylink DJ, Mohan S 1993 Autocrine regulators of MC3T3-E1 cell proliferation J Bone Miner Res 8:157165.
  • 35
    Scharla SH, Strong DD, Baylink DJ, Linkhart TA 1991 1,25-dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts Endocrinology 129:31393146.
  • 36
    Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ 1992 The 24/25-kDa serum insulin-like growth factor-binding protein is increased in elderly women with hip and spine fractures J Clin Endocrinol Metab 74:2427.
  • 37
    Ernst M, Rodan GA 1990 Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein BP-3 Endocrinology 127:807814.
  • 38
    Mohan S 1993 Insulin-like growth factor binding proteins in bone cell regulation Growth Regul 1:6770.
  • 39
    Narusawa K, Nakamura T, Suzuki K, Matsuoka Y, Lee L-J, Tanaka H, Seino Y 1995 The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy J Bone Miner Res 10:18531864.
  • 40
    Conover CA 1991 Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF action: Evidence for processing of cell-bound IGFBP-3 Endocrinology 129:32593268.
  • 41
    Conover CA 1992 Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism Endocrinology 130:31913199.
  • 42
    Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR 1989 Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I Endocrinology 125:766772.
  • 43
    Oh Y, Muller HL, Pham H, Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on HS578T human breast cancer cells J Biol Chem 268:2604526048.
  • 44
    Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P 1995 The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene Mol Endocrinol 9:361367.